Evidence map›Paper›PMID 33740123›Full record

ArticleActa diabetologica2021

Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture.

Livio Luzi, Michele Carruba, Roberta Crialesi, Stefano Da Empoli, Regina Dagani, Elisabetta Lovati, Antonio Nicolucci, Cesare C Berra, Elisa Cipponeri, Ketty Vaccaro and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Acta diabetologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Impact of COVID-19 pandemic on HbAAdvances in laboratory medicine · 2023
    Article
  9. Narrative Review of the COVID-19 Pandemic's First Two Years in Italy.International journal of environmental research and public health · 2022
    Review
  10. Observational
  11. Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2022
    Review
  12. Article
  13. Assessing Urban Policies in a COVID-19 World.International journal of environmental research and public health · 2022
    Article
  14. Review
  15. Article
  16. Telemedicine and diabetes during the COVID-19 era.Archives of medical sciences. Atherosclerotic diseases · 2022
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Livio LuziDepartment of Biomedical Sciences for Health, University of Milan, Milan, Italy. livio.luzi@unimi.it.ORCID http://orcid.org/0000-0003-3183-0552
Michele CarrubaDepartment of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, Milan, Italy.
Roberta CrialesiNational Institute of Statistics of Italy - ISTAT, Rome, Italy.
Stefano Da EmpoliInstitute for Competitiveness - I-COM, Rome, Italy.
Regina DaganiItalian Diabetes Society Foundation Association - AMD Lombardy, Milan, Italy.
Elisabetta LovatiItalian Diabetes Society - SID Lombardy, Pavia, Italy.
Antonio NicolucciCentre for Outcomes Research and Clinical Epidemiology - CORESEARCH, Pescara, Italy.
Cesare C BerraDepartment of Endocrinology, Nutrition and Metabolic Diseases, IRCCS Multimedica, Via Milanese 300, 20099, Sesto San Giovanni, Milan, Italy.
Elisa CipponeriDepartment of Endocrinology, Nutrition and Metabolic Diseases, IRCCS Multimedica, Via Milanese 300, 20099, Sesto San Giovanni, Milan, Italy.
Ketty VaccaroFondazione CENSIS, Rome, Italy.
Andrea LenziHealth City Institute, Rome, Italy.
MultiMedica · ITUniversity of Milan · ITCenter for Outcomes Research and Clinical Epidemiology · ITIstituto Nazionale di Statistica · ITItalian Society of Physiotherapy · ITPrime Minister's Office · BNSocietà Italiana di Reumatologia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince 2010, more than half of World population lives in Urban Environments. Urban Diabetes has arisen as a novel nosological entity in Medicine. Urbanization leads to the accrual of a number of factors increasing the vulnerability to diabetes mellitus and related diseases. Herein we report clinical-epidemiological data of the Milano Metropolitan Area in the contest of the Cities Changing Diabetes Program. Since the epidemiological picture was taken in January 2020, on the edge of COVID-19 outbreak in the Milano Metropolitan Area, a perspective addressing potential interactions between diabetes and obesity prevalence and COVID-19 outbreak, morbidity and mortality will be presented. To counteract lock-down isolation and, in general, social distancing a pilot study was conducted to assess the feasibility and efficacy of tele-monitoring via Flash Glucose control in a cohort of diabetic patients in ASST North Milano.

methodsData presented derive from 1. ISTAT (National Institute of Statistics of Italy), 2. Milano ATS web site (Health Agency of Metropolitan Milano Area), which entails five ASST (Health Agencies in the Territories). A pilot study was conducted in 65 screened diabetic patients (only 40 were enrolled in the study of those 36 were affected by type 2 diabetes and 4 were affected by type 1 diabetes) of ASST North Milano utilizing Flash Glucose Monitoring for 3 months (mean age 65 years, HbA1c 7,9%. Patients were subdivided in 3 groups using glycemic Variability Coefficient (VC): a. High risk, VC > 36, n. 8 patients; Intermediate risk 20 < VC < 36, n. 26 patients; Low risk VC < 20, n. 4 patients. The control group was constituted by 26 diabetic patients non utilizing Flash Glucose monitoring.

resultsIn a total population of 3.227.264 (23% is over 65 y) there is an overall prevalence of 5.65% with a significant difference between Downtown ASST (5.31%) and peripheral ASST (ASST North Milano, 6.8%). Obesity and overweight account for a prevalence of 7.8% and 27.7%, respectively, in Milano Metropolitan Area. We found a linear relationship (R = 0.36) between prevalence of diabetes and aging index. Similarly, correlations between diabetes prevalence and both older people depending index and structural dependence index (R = 0.75 and R = 0.93, respectively), were found. A positive correlation (R = 0.46) with percent of unoccupied people and diabetes prevalence was also found. A reverse relationship between diabetes prevalence and University level instruction rate was finally identified (R = - 0.82). Our preliminary study demonstrated a reduction of Glycated Hemoglobin (p = 0.047) at 3 months follow-up during the lock-down period, indicating Flash Glucose Monitoring and remote control as a potential methodology for diabetes management during COVID-19 lock-down. HYPOTHESIS AND DISCUSSION: The increase in diabetes and obesity prevalence in Milano Metropolitan Area, which took place over 30 years, is related to several environmental factors. We hypothesize that some of those factors may have also determined the high incidence and virulence of COVID-19 in the Milano area. Health Agencies of Milano Metropolitan Area are presently taking care of diabetic patients facing the new challenge of maintaining sustainable diabetes care costs in light of an increase in urban population and of the new life-style. The COVID-19 pandemic will modify the management of diabetic and obese patients permanently, via the implementation of approaches that entail telemedicine technology. The pilot study conducted during the lock-down period indicates an improvement of glucose control utilizing a remote glucose control system in the Milano Metropolitan Area, suggesting a wider utilization of similar methodologies during the present "second wave" lock-down.

Indexed as

QuarantineTelemedicineAdultAgedAged, 80 and overBlood Glucose Self-MonitoringCommunicable Disease ControlCOVID-19Diabetes MellitusFemaleGlycemic ControlHumansIncidenceItalyMaleMiddle AgedCOVID-19Diabetes and obesity prevalenceTelemonitoring of blood glucoseUrban diabetes

Identifiers

PMID33740123
PMCPMC7977495
OpenAlexW3139211254

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.